Tofa For UC

Tofa For UC

Contact

 If you are interested in participating in the study or want to learn more, please get in touch. Contact us
This study is now recruiting. Learn more about enrolling here.

Description
The purpose of this research study is to help us understand how well tofacitinib works as a treatment for ulcerative colitis or indeterminate colitis in pediatric patients. We are looking to enroll, males or females ages 6 to 21 years old with a diagnosis of ulcerative colitis or indeterminate colitis who have started tofacitinib therapy prescribed by their primary gastroenterologist within the past 2 weeks or will be starting tofafacitinib within 1 month.

Eligibility and criteria
IRB Number:
20-017316
Eligible age range:
6 years - 21 years
Clinical trial phase:
N/A
Official title:
An Observational Study of the Natural History of Tofacitinib for Clinical Treatment of Severe Pediatric Ulcerative Colitis and Indeterminate Colitis

Related specialties
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.